{"id":446612,"title":"Notice of Intent to Amend the Prescription Drug List (PDL): Brimonidine  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:23:30.028000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-brimonidine.html?wbdisable=false","snippet":"Notice of Intent to Amend the Prescription Drug List (PDL): Brimonidine November 15, 2021 Our file number: 21-119262-176 The purpose of this Notice of Intent to Amend is to notify the revision of brimonidine or its salts on the Prescription Drug List (PDL), by adding a qualifier.…","rawSnapshotUrl":"/api/snapshots/raw/446612","browseUrl":"https://replay.healtharchive.ca/job-6/20260103122330/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-brimonidine.html?wbdisable=false#ha_snapshot=446612","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}